Study | Treatment 1 | Treatment 2 | RR | 95% CI lower limit | 95% CI upper limit |
Shah 2013 | Levosimendan + Dobutamine | Milrinone + Dobutamine | 0.3333 | 0.0142 | 7.8035 |
Study | Treatment 1 | Treatment 2 | RR | 95% CI lower limit | 95% CI upper limit |
Shah 2013 | Levosimendan + Dobutamine | Milrinone + Dobutamine | 0.3333 | 0.0142 | 7.8035 |